Dashboard
Manage Tickers

PRTA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

novo-nordisks-100-million-coramitug-shows-promise-in-reducing-heart-failure-biomarker
Novo Nordisk's $100 Million Coramitug Show...
11/12/2025 14:24:43

Novo Nordisk's Coramitug cut NT-proBNP levels and was well tolerated in a Phase 2 ATTR-CM trial, paving the way for its Pha...

prothena-presents-phase-2-clinical-study-data-for-coramitug-for-treatment-of-attr-amyloidosis-with-cardiomyopathy-american-heart-associations-circulation-journal
Prothena Presents Phase 2 Clinical Study D...
11/11/2025 14:03:42

Prothena Corporation plc (NASDAQ:PRTA) announced the publication of Phase 2 clinical trial data for coramitug (formerly PRX004)...

hc-wainwright--co-maintains-buy-on-prothena-corp-raises-price-target-to-30
HC Wainwright & Co. Maintains Buy on Proth...
11/07/2025 19:50:14

HC Wainwright & Co. analyst Andrew S. Fein maintains Prothena Corp (NASDAQ:PRTA) with a Buy and raises the price target ...

rbc-capital-maintains-sector-perform-on-prothena-corp-raises-price-target-to-11
RBC Capital Maintains Sector Perform on Pr...
11/07/2025 19:21:26

RBC Capital analyst Brian Abrahams maintains Prothena Corp (NASDAQ:PRTA) with a Sector Perform and raises the price target f...

prothena-corp-q3-adj-eps-068-beats-069-estimate-sales-2415m-miss-6639m-estimate
Prothena Corp Q3 Adj. EPS $(0.68) Beats $(...
11/06/2025 21:17:38

Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(0.69)...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

piper-sandler-maintains-overweight-on-prothena-corp-raises-price-target-to-36
Piper Sandler Maintains Overweight on Prot...
10/28/2025 11:58:11

Piper Sandler analyst Yasmeen Rahimi maintains Prothena Corp (NASDAQ:PRTA) with a Overweight and raises the price target fro...

deep-dive-into-prothena-corp-stock-analyst-perspectives-7-ratings
Deep Dive Into Prothena Corp Stock: Analys...
10/07/2025 21:01:14

hc-wainwright--co-maintains-buy-on-prothena-corp-raises-price-target-to-20
HC Wainwright & Co. Maintains Buy on Proth...
10/07/2025 14:12:47

HC Wainwright & Co. analyst Andrew S. Fein maintains Prothena Corp (NASDAQ:PRTA) with a Buy and raises the price target ...

prothenas-partner-bristol-myers-squibb-receives-fast-track-designation-from-the-fda-for-bms-986446-for-the-treatment-of-alzheimers-disease
Prothena's Partner Bristol Myers Squibb Re...
10/01/2025 21:12:04

Prothena Corporation plc (NASDAQ:PRTA), announced today that Bristol Myers Squibb communicated in a press release that the U.S....

alibaba-to-rally-more-than-12-here-are-10-top-analyst-forecasts-for-tuesday
Alibaba To Rally More Than 12%? Here Are 1...
09/02/2025 12:05:01

jmp-securities-maintains-market-outperform-on-prothena-corp-lowers-price-target-to-11
JMP Securities Maintains Market Outperform...
09/02/2025 11:41:15

JMP Securities analyst Jason Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and lowers the price targ...

fda-tightens-safety-guidelines-for-biogen-leqembi-alzheimers-therapy
FDA Tightens Safety Guidelines For Biogen ...
08/29/2025 14:09:13

The FDA now requires earlier MRI screening for Alzheimer's drug Leqembi to detect ARIA-E, a rare but serious side effect, a...

prothena-reports-non-competitive-brain-swelling-rates-in-early-alzheimers-study
Prothena Reports Non-Competitive Brain Swe...
08/28/2025 17:37:22

Prothena reported ASCENT trial data showing strong amyloid plaque reduction but high ARIA-E rates for Alzheimer's drug PRX0...

piper-sandler-maintains-overweight-on-prothena-corp-lowers-price-target-to-15
Piper Sandler Maintains Overweight on Prot...
08/28/2025 14:27:47

Piper Sandler analyst Yasmeen Rahimi maintains Prothena Corp (NASDAQ:PRTA) with a Overweight and lowers the price target fro...

what-4-analyst-ratings-have-to-say-about-prothena-corp
What 4 Analyst Ratings Have To Say About P...
08/28/2025 13:00:54

chardan-capital-maintains-buy-on-prothena-corp-maintains-18-price-target
Chardan Capital Maintains Buy on Prothena ...
08/28/2025 12:01:53

Chardan Capital analyst Rudy Li maintains Prothena Corp (NASDAQ:PRTA) with a Buy and maintains $18 price target.

prothena-reports-phase-1-results-for-prx012-in-alzheimers-explores-partnerships-to-advance-prx012-and-tfr-linked-preclinical-program
Prothena Reports Phase 1 Results For PRX01...
08/27/2025 20:15:00

As previously communicated, Prothena plans to explore potential partnership interest to advance PRX012 and its preclinical PRX0...

Core News & Articles
Prothena And Novo Nordisk Announce Coramit...
08/06/2025 13:06:23

rbc-capital-maintains-sector-perform-on-prothena-corp-lowers-price-target-to-10
RBC Capital Maintains Sector Perform on Pr...
08/05/2025 14:08:32

RBC Capital analyst Brian Abrahams maintains Prothena Corp (NASDAQ:PRTA) with a Sector Perform and lowers the price target f...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION